Content

Welcome to the CJU website » LOG IN

Details

Remission of hormone-refractory prostate cancer attributed to Essiac
Al-Sukhni Wigdan; Grunbaum Ami; Fleshner Neil; Division of Urology, The Princess Margaret Hospital, University of Toronto, Toro
Oct 2005 (Vol. 12, Issue 5, Pages( 2841 - 2842)

    Abstract

    Text-Size + 

  • Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.

Current Issue

Feb 2017, Vol.24 No.1
canadian journal of urology mobile

canadian journal of urology